S'abonner

Transversus abdominis plane block with liposomal bupivacaine versus continuous epidural analgesia for major abdominal surgery: The EXPLANE randomized trial - 17/01/22

Doi : 10.1016/j.jclinane.2021.110640 
Alparslan Turan, M.D. a, b, , Barak Cohen, M.D. a, c, Hesham Elsharkawy, M.D., MBA a, d, Kamal Maheshwari, M.D. a, b, Loran Mounir Soliman, M.D. b, Rovnat Babazade, M.D. e, Sabry Ayad, M.D. a, b, Manal Hassan, M.D. b, Nabil Elkassabany, M.D. f, Hani A. Essber, M.D. a, Hermann Kessler, M.D. g, Guangmei Mao, PhD a, h, Wael Ali Sakr Esa, M.D.,PhD a, b, Daniel I. Sessler, M.D. a

for the EXPLANE Study Group

a Department of Outcomes Research, Cleveland Clinic, United States of America 
b Department of General Anesthesiology, Cleveland Clinic, United States of America 
c Division of Anesthesiology, Intensive Care, and Pain Management, Tel-Aviv Medical Center, Sackler Faculty of Medicine, Tel-Aviv University, Tel-Aviv, Israel 
d Pain Center, Anesthesiology Department, MetroHealth, Case Western Reserve University, OH, United States of America 
e Department of Anesthesiology, University of Texas Medical Branch of Galveston, TX, United States of America 
f Department of Anesthesiology and Critical Care, University of Pennsylvania, Philadelphia, United States of America 
g Department of Colorectal Surgery, Cleveland Clinic, United States of America 
h Department of Quantitative Health Sciences, Cleveland Clinic 

Corresponding author at: Department of Outcomes Research, Anesthesiology Institute, Cleveland Clinic, 9500 Euclid Avenue, P-77, Cleveland, OH, 44195, United States of America.Department of Outcomes ResearchAnesthesiology InstituteCleveland Clinic9500 Euclid Avenue, P-77OHCleveland44195United States of America

Abstract

Objective

Compare transversus abdominis plane (TAP) blocks with liposomal bupivacaine were to epidural analgesia for pain at rest and opioid consumption in patients recovering from abdominal surgery.

Background

ERAS pathways suggest TAP blocks in preference to epidural analgesia for abdominal surgery. However, the relative efficacies of TAP blocks and epidural analgesia remains unknown.

Methods

Patients having major abdominal surgery were enrolled at six sites and randomly assigned 1:1 to thoracic epidural analgesia or bilateral/4-quadrant TAP blocks with liposomal bupivacaine. Intravenous opioids were used as needed. Non-inferiority margins were a priori set at 1 point on an 11-point pain numeric rating scale for pain at rest and at a 25% increase in postoperative opioid consumption.

Results

Enrollment was stopped per protocol at 3rd interim analysis after crossing an a priori futility boundary. 498 patients were analyzed (255 had TAP blocks and 243 had epidurals). Pain scores at rest in patients assigned to TAP blocks were significantly non-inferior to those given epidurals, with an estimated difference of 0.09 points (CI: −0.12, 0.30; noninferiority P < 0.001). Opioid consumption during the initial 3 postoperative days in TAP patients was not non-inferior to epidurals, with an estimated ratio of geometric means of 1.37 (CI: 1.05, 1.79; non-inferiority P = 0.754). However, the absolute difference was only 21 mg morphine equivalents over the 3 days. Patients with epidurals were more likely to experience mean arterial pressures <65 mmHg than those given TAP blocks: 48% versus 31%, P = 0.006.

Conclusion

Pain scores at rest during the initial three days after major abdominal surgery were similar. Patients assigned to TAP blocks required more opioid then epidural patients but had less hypotension. Clinicians should reconsider epidural analgesia in patients at risk from hypotension.

Trial Registration: ClinicalTrials.gov Identifier: NCT02996227.

Le texte complet de cet article est disponible en PDF.

Highlights

Pain management included two separate outcomes: pain scores at rest, and total opioid consumption during the initial 72 postoperative hours.
Opioid consumption was defined as the total amount used from the end of surgery until the third postoperative day, converted to morphine sulphate equivalents.
Pain was assessed with a verbal response scale which ranges from 0 to 10 points, with 10 being worst.
Pain scores at rest were recorded every 30 min for the first 2 postoperative hours, and then every 4 h while awake for 72 h.
Pain scores and opioid consumption were recorded in patients' medical records by care-givers, and collected by investigators who also verified documentation in medical records.
There were six secondary outcomes.
(1) Opioid-related side effects, per the Opioid–Related Symptom Distress Scale (ORSDS)16 which was evaluated the first three postoperative mornings while patients remained hospitalized.
(2) Recovery after anesthesia which was evaluated on the first and third morning with the Quality of Recovery scale (QoR).17 (3) Postoperative hospital length of stay, defined as time from the end of surgery to discharge from hospital.
(4) Cost effectiveness of liposomal bupivacaine.
(5) Activity, defined as the total duration of time patients spent sitting or standing, as determined by the mobile monitoring system during the initial 72 postoperative hours.
(6) Hemodynamic instability, defined as mean arterial pressure (MAP) <55 mmHg or systolic blood pressure < 80 mmHg.
Analyses of activity and hypotension were restricted to patients with continuous postoperative monitoring.
There were also two a priori exploratory outcomes: 1) hypoxemic events, defined as area-under-the-curve for saturation < 90% among patients with continuous monitoring; and, 2) persistent postoperative incisional pain, defined by presence of pain at three months and its characteristics as determined by the DN4 Test18 and Modified Brief Pain Inventory (MBPI)19 questionnaires.

Le texte complet de cet article est disponible en PDF.

Keywords : Transversus abdominis plane block, Liposomal bupivacaine, Epidural analgesia, Exparel, Abdominal surgery, TAP blocks


Plan


© 2021  Elsevier Inc. Tous droits réservés.
Ajouter à ma bibliothèque Retirer de ma bibliothèque Imprimer
Export

    Export citations

  • Fichier

  • Contenu

Vol 77

Article 110640- mai 2022 Retour au numéro
Article précédent Article précédent
  • Impact of a continuous enhanced cardio-respiratory monitoring pathway on cardio-respiratory complications after bariatric surgery: A retrospective cohort study
  • Chenchen Tian, Laura Hawryluck, George Tomlinson, Frances Chung, Scott Beattie, Matthew Miller, Najia Hassan, David T. Wong, Jean Wong, Julie Hudson, Timothy Jackson, Mandeep Singh
| Article suivant Article suivant
  • Diurnal blood pressure variation in adults after abdominal surgery–An observational cohort study
  • Barak Cohen, Eva Rivas, Xuan Pu, Kamal Maheshwari, Jorge A. Araujo-Duran, Oguz Turan, Andrew Volio, Esra Kutlu Yalcin, Alparslan Turan

Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.

Déjà abonné à cette revue ?

Elsevier s'engage à rendre ses eBooks accessibles et à se conformer aux lois applicables. Compte tenu de notre vaste bibliothèque de titres, il existe des cas où rendre un livre électronique entièrement accessible présente des défis uniques et l'inclusion de fonctionnalités complètes pourrait transformer sa nature au point de ne plus servir son objectif principal ou d'entraîner un fardeau disproportionné pour l'éditeur. Par conséquent, l'accessibilité de cet eBook peut être limitée. Voir plus

Mon compte


Plateformes Elsevier Masson

Déclaration CNIL

EM-CONSULTE.COM est déclaré à la CNIL, déclaration n° 1286925.

En application de la loi nº78-17 du 6 janvier 1978 relative à l'informatique, aux fichiers et aux libertés, vous disposez des droits d'opposition (art.26 de la loi), d'accès (art.34 à 38 de la loi), et de rectification (art.36 de la loi) des données vous concernant. Ainsi, vous pouvez exiger que soient rectifiées, complétées, clarifiées, mises à jour ou effacées les informations vous concernant qui sont inexactes, incomplètes, équivoques, périmées ou dont la collecte ou l'utilisation ou la conservation est interdite.
Les informations personnelles concernant les visiteurs de notre site, y compris leur identité, sont confidentielles.
Le responsable du site s'engage sur l'honneur à respecter les conditions légales de confidentialité applicables en France et à ne pas divulguer ces informations à des tiers.


Tout le contenu de ce site: Copyright © 2025 Elsevier, ses concédants de licence et ses contributeurs. Tout les droits sont réservés, y compris ceux relatifs à l'exploration de textes et de données, a la formation en IA et aux technologies similaires. Pour tout contenu en libre accès, les conditions de licence Creative Commons s'appliquent.